A division of the NHS that sources goods for hospitals and healthcare organisations signs up for 8,526 sq ft of office space at Sci-Tech Daresbury. Tony McDonough reports
Sci-Tech Daresbury has announced a new letting to a division of the NHS.
NHS Supply Chain manages the sourcing, delivery, and supply of healthcare products, services, and food has agreed a lease on 8,526 sq ft of office space at the Liverpool city region science and innovation campus.
It works on behalf of NHS trusts and healthcare organisations across England and Wales and this deal will see it bring its Chester and Warrington teams together on the second floor of the Techspace One development.
John Leake, business growth director at Sci-Tech Daresbury, said: “We’re beyond delighted to welcome NHS Supply Chain to our growing community at Sci-Tech Daresbury.
“Their work is fundamental to the success of the NHS and to the health of millions of people across the country. By joining our campus, NHS Supply Chain will benefit from being part of a thriving network of organisations pushing the boundaries of healthcare and life sciences innovation.
“Its presence is a major boost to our vision of creating a world-class hub for science, technology, and healthcare.”
Earlier this month LBN revealed that Liverpool City Region Combined Authority is to consider investing a further £7.5m into an expansion of the Sci-Tech Daresbury science and innovation campus.
Project Violet phase two secured planning consent in December 2023. It will comprise a 60,000 sq ft laboratory facility and a 23,000 sq ft office building. Combined they could create capacity for around 250 people.
READ MORE: University to open £100m Liverpool AI facility
In 2024 Sci-Tech Daresbury, a joint venture between Langtree, the Science and Technology Facilities Council and Halton Council, secured £9.5m for the laboratory element from the city region’s Innovation Zone funding.
This latest £7.5m would be invested in the office building which, on its own, could create capacity for 100 jobs. Work on Violet phase two is planned to start in summer 2026. A decision will be made on the £7.5m following the submission of a full business case.